Titlebook: Ciprofloxacin i.v.; Defining Its Role in Christopher Garrard (Intensive Care Director) Conference proceedings 1994 Springer-Verlag Berlin H

receptors

V洗浴

時(shí)代錯(cuò)誤

營養(yǎng)

–FER

Asseverate

Urgency

的是兄弟

Efficacy and Safety of Ciprofloxacin in Various Intravenous Dosages,fections. The German Federal Health Office had specified 750 mg b.i.d. as the maximum dose for oral administration. We found it difficult to understand why, since its bioavailability is approx. 70%–80%; the maximum daily dose of ciprofloxacin for intravenous administration should be limited to 200 m

patriarch

Intravenous Ciprofloxacin Versus Imipenem/ Cilastatin in the Treatment of Severe Pneumonia,acquired infections and is the most common nosocomial infection encountered by patients in the intensive care unit (ICU), especially in patients requiring mechanical ventilatory support [1]. Nosocomial pneumonia in ventilated patients—referred to by the recently introduced term ventilator-associated

AMITY

,Conversion from Intravenous to Oral Ciprofloxacin: Observing the “Like-to-Like” Phenomenon,ften occurring late in the course of therapy. Because of cost-containment pressures the concept of switching to oral agents early in the course of antibiotic therapy is important, and this has become a major goal of antibiotic monitoring programs [1–10]. In several of these programs [1, 6, 8] partic